Today: 29 April 2026
Browse Category

NASDAQ:CGC 7 November 2025 - 24 December 2025

Canopy Growth (CGC) Stock on Dec. 24, 2025: Schedule III Executive Order, MTL Cannabis Deal, and the Latest Forecasts

Canopy Growth (CGC) Stock on Dec. 24, 2025: Schedule III Executive Order, MTL Cannabis Deal, and the Latest Forecasts

Canopy Growth shares closed at $1.40 on Dec. 23, up 6.06%, after heavy trading and sharp swings throughout December. The volatility followed a Dec. 18 White House executive order directing marijuana rescheduling from Schedule I to III. Trading volume spiked to over 216 million shares on Dec. 18, with implied volatility near 143%. U.S. exchanges operated a shortened session on Dec. 24.
24 December 2025
····
Tilray Stock Surges as Trump Schedule III Buzz Collides With New Vape Launch and Reverse Split Fallout

Tilray Stock Surges as Trump Schedule III Buzz Collides With New Vape Launch and Reverse Split Fallout

Tilray Brands shares surged December 15 as global cannabis stocks rallied on reports that Donald Trump may push to reclassify marijuana as a Schedule III drug. The move, which would ease federal restrictions but stop short of legalization, fueled investor optimism over potential tax and banking benefits for the industry. Tilray also completed a 1-for-10 reverse stock split and reported momentum in its Canadian portfolio.
15 December 2025
····
Canopy Growth Corporation Stock (CGC) Surges on Trump Marijuana Rescheduling Reports: Latest News, Forecasts, and What Comes Next (Dec. 15, 2025)

Canopy Growth Corporation Stock (CGC) Surges on Trump Marijuana Rescheduling Reports: Latest News, Forecasts, and What Comes Next (Dec. 15, 2025)

Canopy Growth shares surged as much as 17.9% in early European trading Monday, extending Friday’s 54% jump, after reports that President Trump may reclassify marijuana as a Schedule III drug. Trading volume spiked, with speculation focused on potential U.S. federal reform and its impact on cannabis industry taxes. No final decision has been confirmed by the White House.
15 December 2025
··
Top Stock Gainers Today (Dec. 12, 2025, 12:30 p.m. ET): cbdMD, Canopy Growth, Tilray Lead a Cannabis-Fueled Rally

Top Stock Gainers Today (Dec. 12, 2025, 12:30 p.m. ET): cbdMD, Canopy Growth, Tilray Lead a Cannabis-Fueled Rally

cbdMD (YCBD) surged 126.6% to $1.43 by 12:30 p.m. ET, leading US stock gainers amid reports President Trump may ease federal marijuana restrictions. Major indexes fell, with the S&P 500 down 1.05% and Nasdaq 100 off 1.8%. Small-cap and cannabis stocks outperformed on policy speculation and company news.
12 December 2025
····
Canopy Growth Corporation Stock (CGC) Jumps on Trump Marijuana Rescheduling Report — News, Forecasts, and What Investors Are Watching (Dec. 12, 2025)

Canopy Growth Corporation Stock (CGC) Jumps on Trump Marijuana Rescheduling Report — News, Forecasts, and What Investors Are Watching (Dec. 12, 2025)

Canopy Growth shares jumped about 21% in premarket trading Friday after reports said President Trump is expected to direct federal agencies to reclassify marijuana as a Schedule III drug. The move, first reported by the Washington Post and cited by Reuters, triggered a surge across US-listed cannabis stocks. No final decision has been made, according to a White House official.
12 December 2025
····
Canopy Growth (CGC) Stock Outlook December 2025: Debt Prepayment, Lawsuit Pressure and a High‑Risk Turnaround

Canopy Growth (CGC) Stock Outlook December 2025: Debt Prepayment, Lawsuit Pressure and a High‑Risk Turnaround

Canopy Growth shares closed at $1.15 on December 5, down 4.96%, but remain up about 13–14% over the last 10 sessions. Q2 FY2026 net revenue rose 6% to C$66.7 million, with gross margin improving to 33%. Net loss narrowed sharply to C$1.6 million from C$131.6 million a year earlier. The company ended the quarter with C$298 million in cash, exceeding its total debt.
6 December 2025
··
Canopy Growth (CGC) Lifts ‘Going Concern’ Doubts as Cash Tops Debt; Q2 FY2026 Shows 30% Canada Adult‑Use Growth

Canopy Growth (CGC) Lifts ‘Going Concern’ Doubts as Cash Tops Debt; Q2 FY2026 Shows 30% Canada Adult‑Use Growth

Canopy Growth reported Q2 FY2026 net revenue of C$66.7 million, up 6% year over year, and ended the quarter with C$298 million in cash, exceeding total debt by C$70 million. The company lifted its going-concern warning. Shares rose as much as 19% premarket before turning volatile. Operating loss narrowed to C$17 million, down 63% from a year ago.
7 November 2025
·

Stock Market Today

  • VTI Falls 0.3% as PLTR Stock Declines Amid Heavy Insider Selling
    April 29, 2026, 2:24 PM EDT. VTI, the Vanguard Total Stock Market ETF, dropped 0.3% today, weighed down by a 3.4% decline in Palantir Technologies (PLTR) shares. Notable VTI holdings like Nvidia (-1.2%), Microsoft (-1.2%), and Apple (-0.8%) also contributed to losses. PLTR insiders have sold 227 times in six months without any purchases, including major sales by Peter Thiel and CEO Alexander Karp, signaling potential negative sentiment. Despite recent analyst buy ratings from Mizuho, Citigroup, and others, RBC Capital issued an underperform rating. Investors can monitor PLTR's insider activity and analyst outlook via Quiver Quantitative's dashboards. The median PLTR price target remains incomplete in reports, further highlighting investor uncertainty.

Latest article

Why Rising Dragon Acquisition Stock Surged as RDAC Seeks More Time for HZJL SPAC Deal

Why Rising Dragon Acquisition Stock Surged as RDAC Seeks More Time for HZJL SPAC Deal

29 April 2026
Rising Dragon Acquisition Corp. shares surged over 400% to $21.72 Wednesday after the SPAC proposed extending its merger deadline with HZJL Cayman Limited. The company called a May 28 shareholder meeting to vote on extending the deadline by up to 15 months. Rising Dragon’s board urged shareholders to approve the extension. The HZJL merger has not closed.
Upstart Stock Falls After $1.25 Billion Fortress Deal: Why Investors Are Still Wary

Upstart Stock Falls After $1.25 Billion Fortress Deal: Why Investors Are Still Wary

29 April 2026
Upstart Holdings shares fell $2.09 to $30.77 Wednesday after announcing Fortress Investment Group affiliates will buy up to $1.25 billion in consumer loans over 15 months. March loan originations rose 60% year over year to $1.263 billion. In 2025, Upstart’s revenue climbed 64% to $1.0 billion, with net income of $53.6 million after a $129 million loss in 2024. Upstart plans to apply for a national bank charter.
Intel Stock Hits Record High as Google AI Chip Report Puts Foundry Turnaround in Play

Intel Stock Hits Record High as Google AI Chip Report Puts Foundry Turnaround in Play

29 April 2026
Intel shares surged 10% Wednesday after reports that Google may use Intel’s EMIB chip-packaging technology in its next AI processor. The stock hit $94.03 before settling at $93.23. Intel recently reported first-quarter revenue of $13.6 billion, up 7% year over year. CFO David Zinsner said some gains came from selling previously shelved chips.
Go toTop